MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
NBY NovaBay Pharmaceuticals
- 0.5299
- +0.0258+5.12%
Close Dec 20 16:00 ET
- 0.5100
- -0.0199-3.76%
Post 19:59 ET
2.59MMarket Cap-0.01P/E (TTM)
0.5299High0.5046Low597.91KVolume0.5166Open0.5041Pre Close360.74KTurnover12.25%Turnover Ratio0.00P/E (Static)4.89MShares9.079052wk High2.43P/B2.59MFloat Cap0.361152wk Low--Dividend TTM4.88MShs Float130156.1979Historical High--Div YieldTTM5.02%Amplitude0.3610Historical Low0.6030Avg Price1Lot Size
NovaBay Pharmaceuticals Stock Analyst Ratings & Price Target
Price Target
Updated: Nov 30, 2024
The average NovaBay Pharmaceuticals stock price target is 0.85 with a max estimate of 0.85 and a min estimate of 0.85
Review NovaBay Pharmaceuticals earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Nov 30, 2024